0001209191-19-020161.txt : 20190319
0001209191-19-020161.hdr.sgml : 20190319
20190319081424
ACCESSION NUMBER: 0001209191-19-020161
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190317
FILED AS OF DATE: 20190319
DATE AS OF CHANGE: 20190319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daniell Richard
CENTRAL INDEX KEY: 0001726096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16174
FILM NUMBER: 19690237
MAIL ADDRESS:
STREET 1: 5 BASEL STREET, PO BOX 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 4951033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD
CENTRAL INDEX KEY: 0000818686
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 BAZEL ST
STREET 2: P O B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
BUSINESS PHONE: 9729267267
MAIL ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 5 BAZEL ST PO B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-17
0
0000818686
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
0001726096
Daniell Richard
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.
5 BASEL STREET
PETACH TIKVA
L3
4951033
ISRAEL
0
1
0
0
Exec. VP, European Commercial
Ordinary Shares
2019-03-17
4
M
0
1297
A
1297
D
Ordinary Shares
2019-03-18
4
S
0
1297
16.6446
D
0
D
Restricted Share Units
2019-03-17
4
M
0
1297
0.00
D
Ordinary Shares
1297
1297
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 16.6400 to $16.6516, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
Restricted share units were granted on March 17, 2016, with 1,297 vesting on each of March 17, 2018, March 17, 2019 and March 17, 2020.
/s/ Dov Bergwerk, as attorney-in-fact for Richard Daniell
2019-03-19